Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Chemicon and MorphoSys sign licensing agreement for research antibodies

Jan. 17, 2006

Ablynx and Centocor sign Nanobodies agreement

Jan. 16, 2006

Sangamo and Pfizer expand research collaboration

Jan. 11, 2006

Xencor and Roche extend research collaboration

Jan. 10, 2006

Crucell licenses STAR technology to Xoma for research

Jan. 10, 2006

Lipid Sciences files IDE for Plasma Delipidation System-2

Jan. 4, 2006

Plk1 inhibitors as tools to study cell division processes

Dec. 28, 2005

New specific Arp2/3 complex inhibitors for the study of actin cytoskeleton dynamics

Dec. 23, 2005

Several classes of lipids modulate tight junctions to enhance drug permeation

Dec. 23, 2005

Gene Logic and Roche sign drug repositioning and development agreement

Dec. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...